US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 2, 2023 (3 years ago)

Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed dissolution specifications - results obtained were below spec average.

What was recalled

Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A., NDC 0378-1270-93

Recalling firm
Aurobindo Pharma USA Inc.
NDC code
0378-1270-93
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1171-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Rasagiline recalls

See all